FDA grants to boost manufacturing, regulatory science

The FDA has made a potential $35 million commitment that aims to improve both drug-making and regulation. The goal of the FDA grants to the National Institute for Pharmaceutical Technology and Education (NIPTE) is to improve drug manufacturing standards.

"Investment in research of drug development and manufacturing will improve America's manufacturing competitiveness and create high-paying jobs at home," according to an NIPTE statement. It will also "help to reverse" offshoring and outsourcing trends by decreasing the cost of manufacture and by improving quality and safety of drugs.

"Progress in this area will mean safer, more efficient and less costly drug production here in the U.S.," says Helen Winkle, director for FDA's Office of Pharmaceutical Sciences, in the statement.

The nonprofit NIPTE says its goal is to "increase science and engineering-based understanding" of drug manufacturing so "novel" technologies can be developed and science-based regulations can be implemented.

- here's the statement


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.